The new study identifies 4,248 CpG sites associated with the risk of seven different types of cancer: breast, colorectal, renal cell, lung, ovarian, prostate and testicular germ cell cancers.
Epigenetic change to DNA associated with cancer risk in ‘multi-omics’ study